Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Open-label, Single-arm, Multi-center Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly

NCT04125836 is registered in ClinicalTrials.gov with Camurus AB as lead sponsor.

NCT NCT04125836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04125836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Open-label, Single-arm, Multi-center Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly
Lead sponsor
Camurus AB
Phase
Phase 3
Overall status
Completed
Start date
October 10, 2019
Completion date
April 24, 2025
Enrollment
135 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly